Taken together, our findings suggest that mir-218-2 promotes glioma progression through the CDC27/APC ubiquitin–proteasome pathway, and promotes the invasion, migration, and actin organization through the modulation of cell junction and focal adhesion proteins (Figure 5J). Here, UBC is linked to glioma.